164 related articles for article (PubMed ID: 29742140)
1. Streptothricin acetyl transferase 2 (Sat2): A dominant selection marker for Caenorhabditis elegans genome editing.
Obinata H; Sugimoto A; Niwa S
PLoS One; 2018; 13(5):e0197128. PubMed ID: 29742140
[TBL] [Abstract][Full Text] [Related]
2. Genome Editing of C. elegans.
Sugi T
Methods Mol Biol; 2017; 1630():247-254. PubMed ID: 28643264
[TBL] [Abstract][Full Text] [Related]
3. The application of somatic CRISPR-Cas9 to conditional genome editing in Caenorhabditis elegans.
Li W; Ou G
Genesis; 2016 Apr; 54(4):170-81. PubMed ID: 26934570
[TBL] [Abstract][Full Text] [Related]
4. Approaches for CRISPR/Cas9 Genome Editing in C. elegans.
Martin CJ; Calarco JA
Methods Mol Biol; 2022; 2468():215-237. PubMed ID: 35320567
[TBL] [Abstract][Full Text] [Related]
5. High-efficiency CRISPR gene editing in C. elegans using Cas9 integrated into the genome.
Schwartz ML; Davis MW; Rich MS; Jorgensen EM
PLoS Genet; 2021 Nov; 17(11):e1009755. PubMed ID: 34748534
[TBL] [Abstract][Full Text] [Related]
6. Highly Efficient, Rapid and Co-CRISPR-Independent Genome Editing in
Prior H; Jawad AK; MacConnachie L; Beg AA
G3 (Bethesda); 2017 Nov; 7(11):3693-3698. PubMed ID: 28893845
[TBL] [Abstract][Full Text] [Related]
7. A new dominant selectable marker for use in Cryptococcus neoformans.
McDade HC; Cox GM
Med Mycol; 2001 Feb; 39(1):151-4. PubMed ID: 11270405
[TBL] [Abstract][Full Text] [Related]
8. Nourseothricin N-acetyl transferase: a positive selection marker for mammalian cells.
Kochupurakkal BS; Iglehart JD
PLoS One; 2013; 8(7):e68509. PubMed ID: 23861913
[TBL] [Abstract][Full Text] [Related]
9. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
Meng X; Zhou H; Xu S
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
[TBL] [Abstract][Full Text] [Related]
10. Efficient Genome Editing in Caenorhabditis elegans with a Toolkit of Dual-Marker Selection Cassettes.
Norris AD; Kim HM; Colaiácovo MP; Calarco JA
Genetics; 2015 Oct; 201(2):449-58. PubMed ID: 26232410
[TBL] [Abstract][Full Text] [Related]
11. The gene encoding streptothricin acetyltransferase (sat) as a selectable marker for Leishmania expression vectors.
Joshi PB; Webb JR; Davies JE; McMaster WR
Gene; 1995 Apr; 156(1):145-9. PubMed ID: 7737509
[TBL] [Abstract][Full Text] [Related]
12. Genome Editing of C. elegans.
Sugi T
Methods Mol Biol; 2023; 2637():389-396. PubMed ID: 36773162
[TBL] [Abstract][Full Text] [Related]
13. An Efficient Genome Editing Strategy To Generate Putative Null Mutants in
Wang H; Park H; Liu J; Sternberg PW
G3 (Bethesda); 2018 Nov; 8(11):3607-3616. PubMed ID: 30224336
[TBL] [Abstract][Full Text] [Related]
14. Efficient marker-free recovery of custom genetic modifications with CRISPR/Cas9 in Caenorhabditis elegans.
Arribere JA; Bell RT; Fu BX; Artiles KL; Hartman PS; Fire AZ
Genetics; 2014 Nov; 198(3):837-46. PubMed ID: 25161212
[TBL] [Abstract][Full Text] [Related]
15. Targeted genome editing in Caenorhabditis elegans using CRISPR/Cas9.
Farboud B
Wiley Interdiscip Rev Dev Biol; 2017 Nov; 6(6):. PubMed ID: 28810059
[TBL] [Abstract][Full Text] [Related]
16. The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans.
Xu S
J Genet Genomics; 2015 Aug; 42(8):413-21. PubMed ID: 26336798
[TBL] [Abstract][Full Text] [Related]
17. Nourseothricin N-acetyl transferase (NAT), a new selectable marker for nuclear gene expression in
Yang X; Peng J; Pan J
Plant Methods; 2019; 15():140. PubMed ID: 31827577
[TBL] [Abstract][Full Text] [Related]
18. Using Microinjection to Generate Genetically Modified Caenorhabditis elegans by CRISPR/Cas9 Editing.
Iyer J; DeVaul N; Hansen T; Nebenfuehr B
Methods Mol Biol; 2019; 1874():431-457. PubMed ID: 30353529
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9: A new tool for the study and control of helminth parasites.
Du X; McManus DP; French JD; Jones MK; You H
Bioessays; 2021 Jan; 43(1):e2000185. PubMed ID: 33145822
[TBL] [Abstract][Full Text] [Related]
20. Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple
Lombardi L; Oliveira-Pacheco J; Butler G
mSphere; 2019 Mar; 4(2):. PubMed ID: 30867327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
